Amgen Inc. buy The Goldman Sachs Group, Inc.
Start price
04.02.26
/
50%
€282.50
Target price
04.02.27
€350.97
Performance (%)
19.24%
Price
15:28
€331.80
Summary
This prediction is currently active. The prediction currently has a performance of 19.24%. A total of €5.04 was paid as dividends for this prediction. This prediction currently runs until 04.02.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 3.295% | 3.295% |
| iShares Core DAX® | 0.855% | 0.389% |
| iShares Nasdaq 100 | -0.989% | -4.400% |
| iShares Nikkei 225® | -1.781% | -11.216% |
| iShares S&P 500 | 0.057% | 0.778% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $403.00 to $415.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat